OvaScience

Closed

Discovering new fertility treatment options.

Public · Cambridge, United States · Founded 2011 · $150.8M raised

Employees
51–200
Founded
2011
Business Model
B2C
Total Funding
$150.8M
Last Round
$50.0M Corporate RoundDec 2018
Rounds
5
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 7 investors for this company. The full record is or through the API.

About

OvaScience was a publicly traded biotechnology company focused on female infertility, applying novel science around egg precursor cells (EggPCSM cells) to improve egg quality and IVF outcomes. Founded in 2011 and based in Cambridge and later Waltham, Massachusetts, the company completed a reverse merger with Millendo Therapeutics in December 2018, ceasing to operate as OvaScience. The domain now redirects to an unrelated site.

Summary

OvaScience is a Biotech company based in Cambridge, United States, founded in 2011. It has raised $150.8M in total across 5 rounds, most recently a $50.0M Corporate Round in Dec 2018. Investors include General Catalyst, Bessemer Venture Partners and Longwood Fund.

Funding History

Corporate RoundCorporate RoundDec 2018
$50.0M

Sign up to see all 5 events

Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

OvaScience on Indexed.vc
<a href="https://indexed.vc/companies/ovascience"><img src="https://indexed.vc/api/badge/company/ovascience" alt="OvaScience on Indexed.vc" width="260" height="76" /></a>